MRK logo

MRK
Merck & Co Inc

25,724
Mkt Cap
$400.63B
Volume
7.45M
52W High
$113.89
52W Low
$73.31
PE Ratio
15.00
MRK Fundamentals
Price
$112.98
Prev Close
$110.27
Open
$110.12
50D MA
$104.71
Beta
0.31
Avg. Volume
12.62M
EPS (Annual)
$6.74
P/B
5.44
Rev/Employee
$852,973.33
Loading...
Loading...
News
all
press releases
Merck & Co., Inc. (NYSE:MRK) Issues FY 2026 Earnings Guidance
Merck & Co., Inc. (NYSE:MRK) updated its FY 2026 earnings guidance. The company provided EPS guidance of 5.000-5.150 for the period, compared to the consensus estimate of 5.860. The company also...
MarketBeat·2h ago
News Placeholder
More News
News Placeholder
Merck (MRK) Q4 Earnings and Revenues Beat Estimates
Merck (MRK) delivered earnings and revenue surprises of +0.62% and +1.33%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3h ago
News Placeholder
Merck & Co., Inc. $MRK Shares Sold by Jones Financial Companies Lllp
Jones Financial Companies Lllp lessened its holdings in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 1.8% during the third quarter, according to the company in its most recent Form 13F...
MarketBeat·4h ago
News Placeholder
Merck & Co., Inc., Rahway, N.J., USA Announces Fourth-Quarter and Full-Year 2025 Financial Results; Highlights Progress Advancing Broad, Diverse Pipeline
Merck & Co., Inc., Rahway, N.J., USA (NYSE: MRK), known as MSD outside the United States and Canada, today announced financial results for the fourth quarter and full year of 2025. 'In 2025, we...
Business Wire·4h ago
News Placeholder
Market Indexes Bounce Back to Start a New Trading Week
Improved Manufacturing data joined another strong tranche of Q4 earnings reports today.
Zacks·17h ago
News Placeholder
Market Awaits January Manufacturing Numbers
Market Awaits January Manufacturing Numbers.
Zacks·24h ago
News Placeholder
Six More Weeks of Q4 Earnings Season?
We're quiet to start a new trading week, but this is both Jobs Week and the busiest Q4 earnings week thus far.
Zacks·1d ago
News Placeholder
What's in Store for These 5 Pharma Bigwigs This Earnings Season?
As earnings season accelerates, pharma heavyweights LLY, MRK, NVO, BMY and PFE prepare to reveal their Q4 results amid a strong sector start.
Zacks·1d ago
News Placeholder
Mediolanum International Funds Ltd Raises Position in Merck & Co., Inc. $MRK
Mediolanum International Funds Ltd boosted its position in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 37.9% in the 3rd quarter, according to the company in its most recent 13F filing...
MarketBeat·2d ago
News Placeholder
Merck & Co., Inc. $MRK is Atle Fund Management AB's 4th Largest Position
Atle Fund Management AB lifted its stake in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 15.6% during the third quarter, according to the company in its most recent Form 13F filing with...
MarketBeat·2d ago
<
1
2
...
>

Latest MRK News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.